Discover

COR
Cencora, Inc.
318.04
200 x 303.27
40 x 322.60
bid
ask
+
3.35
1.06%
120 @ 07:30 PM
318.04 +0.00 (0.00%)
Ytd-5.84%
1y4.88%
313.13
day range
320.21
252.74
52 week range
374.75
Open314.74Prev Close314.69Low313.13High320.21Mkt Cap60.69B
Vol784.71KAvg Vol1.55MEPS13.47P/E23.61Forward P/E16.07
Beta0.57Short Ratio3.73Inst. Own99.59%Dividend2.40Div Yield0.76
Ex Div Date08-14Earning11-0450-d Avg301.70200-d Avg323.651yr Est369.31
Earning
DateForEstimateReportedSurprisesurprise %
2026-11-042026-094.51N/AN/AN/A
2026-08-052026-064.354.480.132.99%
2026-05-062026-034.824.75-0.07-1.45%
2026-02-042025-124.054.080.030.74%
2025-11-052025-093.793.840.051.32%
2025-08-062025-063.8540.153.90%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-19RBC CapitalUpgradeSector Perform
2026-08-11Wells FargoUpgradeOverweightOverweight
2026-08-07Morgan StanleyUpgradeOverweightOverweight
2026-08-07JP MorganUpgradeOverweightOverweight
2026-08-06UBSUpgradeBuyBuy
2026-08-06Evercore ISI GroupUpgradeOutperformOutperform
Profile
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Insider Holder
DateNameRelationQuantityDescription
2026-06-29BATTAGLIA SILVANAOfficer23.62KStock Award(Grant)
2026-06-29CAMPBELL ELIZABETH SOfficer30.76KStock Award(Grant)
2026-03-10CLEARY JAMES F. JR.Chief Financial Officer160.36KConversion of Exercise of derivative security
2025-09-15COLLIS STEVEN HOWARDOfficer and Director305.91KSale
2026-06-17DURCAN DERMOT MARKDirector31.77KPurchase
2026-03-04GREENBERG LON RDirector18.41KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Blackrock Inc.18.21M5.79B9.54%
2026-06-29Vanguard Capital Management LLC12.38M3.94B6.49%
2026-06-29Vanguard Portfolio Management LLC9.61M3.06B5.04%
2026-06-29State Street Corporation9.27M2.95B4.86%
2026-06-29T. Rowe Price Investment Management, Inc.7.41M2.36B3.88%
2026-06-29Price (T.Rowe) Associates Inc7.13M2.27B3.74%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund5.87M1.87B3.08%
2026-03-30VANGUARD INDEX FUNDS-Vanguard 500 Index Fund4.94M1.57B2.59%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund3.99M1.27B2.09%
2026-03-30T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App2.76M876.98M1.45%
2026-06-29iShares Trust-iShares Core S&P 500 ETF2.68M853.76M1.41%
2026-06-29Fidelity Concord Street Trust-Fidelity 500 Index Fund2.50M793.74M1.31%
Dividend
DividendDate
0.62026-08-14
0.62026-05-15
0.62026-02-13
0.62025-11-14
0.552025-08-15
0.552025-05-16
Split
SplitDate
10 : 12014-06-13